04.01.2014 Views

Leprosy Training Module for Medical Officers

Leprosy Training Module for Medical Officers

Leprosy Training Module for Medical Officers

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

• Doses required :<br />

- 100 mg 3 times a day <strong>for</strong> 1 month<br />

- 100 mg 2 times a day <strong>for</strong> 1 month<br />

- 100 mg daily <strong>for</strong> 1 month and then stop the drug<br />

2. Thalidomide :<br />

• It was marketed as a sedative – hypnotic in 1957.<br />

• Withdrawn from the market several years later because of teratogenecity.<br />

• Also effective <strong>for</strong> the treatment of severe ENL and chronic recurrent ENL<br />

reactions as an anti – inflammatory drug.<br />

• Useful in weaning patients off corticosteroids.<br />

• Because of teratogenic effects, thalidomide should never be given to women<br />

of child bearing age.<br />

• Doses required :<br />

- 400 mg a day in 4 divided doses <strong>for</strong> 1 – 2 weeks<br />

- 300 mg a day in 3 divided doses <strong>for</strong> 1 week<br />

- 200 mg a day in 2 divided doses <strong>for</strong> 1 week<br />

- 100 mg a day <strong>for</strong> 1 week and then stop the drug<br />

• Combined treatment with Clofazimine and Thalidomide ( both 300 mg daily )<br />

controls the reactional state of corticosteroid – dependent lepromatous<br />

patients more rapidly than monotherapy with thalidomide alone.<br />

Management of Other Complications :<br />

• Iridocyclitis – Mild cases of iridocyclitis may be treated with topical<br />

application of Atropine and Steroid eye drops or ointments .<br />

More severe cases should be referred to the nearest hospital.<br />

58

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!